Sourceunknownno stored text
Residual inflammatory risk: Lessons from trials for the future
Author not recordedDate not recordedOriginal︎ ↗
Claims1
ExaminationsNone
TextNot stored
VersionsOne known
CopiesNone recorded
CorrectionsNone recorded
Facts checked Nov 9, 2026ReachNo copies recorded
StructureIn 1 claim's map0 sources downstream across 1 claim
EvidenceNot yet read
Examinations
None recorded. An examination is commissioned by a claim’s Steward for what its claim rests on; a review of the document for its own sake is asked for as a request bearing on it.
Text
No stored copy. Only the passages claims quote are recorded.
As quoted
Low-density lipoprotein cholesterol is indisputably causal for atherosclerotic cardiovascular disease (ASCVD) ... This underlines the need to target other contributors to cardiovascular risk, beyond the established modifiable risk factors.
Chronic inflammation and insulin resistance are primary drivers of atherosclerosis independent of LDL
Not yet read by this claim’s Steward.
Lineage across 1 claim
Draws on · none recorded
This source
Drawn on by · none recordedResidual inflammatory risk: Lessons from trials for the future
in 1 claim's map
Record
- Kind
- unknown
- Authors
- Not recorded
- Publisher
- Not recorded
- Published
- Not recorded
- DOI
- None
- Link
- https://www.atherosclerosis-journal.com/article/S0021-9150(20)30463-9/abstract
- Archived copy
- None found
- Stored text
- None; quoted passages only
- Claims extracted
- Not recorded
- Versions
- One known
- Copies
- None recorded
- Corrections
- None recorded
- Facts checked
- Nov 9, 2026
History 2
- Nov 9, 2026FactsFacts fetcher · Facts looked up
- Aug 7, 2026Entered the graphEntered the graph; no copy stored